Bizarre Patents
Wearable Device For Feeding and Observing Birds and Other Flying Animals
A device for feeding and observing flying animals comprising a hat, a support mounted on the hat and extending outward from the hat, and a feeder mounted on the support.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8188137 | HCV protease inhibitors and uses thereof The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same. ... | 05/29/2012 |
| 8168671 | Synthesis of thieno[3,4-b]thiophene, thieno[3,4-b]furan, related compounds and their derivatives and use thereof Inexpensive and facile methods of preparing fused heterocycles such as thieno[3,4-b]thiophene, thieno[3,4-b]furan, related compounds, and their derivatives are disclosed. Also disclosed are regioregular polymers prepared from the fused heterocycles. ... | 05/01/2012 |
| 8158671 | Indole and indoline cyclopropyl amide derivatives as EP4 receptor antagonists The invention is directed to indole and indoline cyclopropyl amide derivatives as EP4 receptor antagonists useful for the treatment of EP4 mediated diseases or conditions, such as acute and chronic pain, osteoarthritis, rheumatoid arthritis and cancer. Pharmaceutica... | 04/17/2012 |
| 8143305 | 2,3-substituted indole derivatives for treating viral infections The present invention relates to 2,3-Substituted Indole Derivatives, compositions comprising at least one 2,3-Substituted Indole Derivative, and methods of using the 2,3-Substituted Indole Derivatives for treating or preventing a viral infection or a virus-related d... | 03/27/2012 |
| 8101646 | Amorphous form of an L-arginine salt of perindopril and processes for preparation thereof In illustrative embodiments, there is provided an amorphous form of L-arginine salt of perindopril which may be particularly suitable for pharmaceutical applications, and processes for preparing said form. ... | 01/24/2012 |
| 8101647 | Spiro-oxindole compounds and their use as therapeutic agents This invention is directed to spiro-oxindole compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment and/or prevention of sodium channel-mediated diseases ... | 01/24/2012 |
| 8101645 | Thienopyrroles and pyrrolothiazoles as new therapeutic agents The present invention is directed to novel compounds of Formula (I) wherein the variables are defined as herein. The compounds of Formula (I) are useful as CRTH2 antagonists and as such would be useful in treating certain c... | 01/24/2012 |
| 8071637 | Dithiolopyrrolones compounds and their therapeutic applications The present invention provides dithiolopyrrolone compounds of the general formula I, and their salts, wherein A is sulfur or carbon, and R1, R2, and R3 are selected from groups defined herein, and wherein when A is sulfur, then B is ... | 12/06/2011 |
| 8044086 | Oxidative degradation products of atorvastatin calcium The present invention relates to oxidative degradation products of atorvastatin calcium and the process of the preparation thereof. The present invention also relates to atorvastatin calcium substantially free of oxidative degradation products and the pharmaceutical... | 10/25/2011 |
| 8039505 | Compounds for modulating T-cells Disclosed are compounds and compositions that modulate T-cells. Such compounds can be used to treat T-cell mediated disease like T-ALL, rheumatoid arthritis, multiple sclerosis, and graft-vs-host disease (GvHD), to name but a few. The compounds have a general struct... | 10/18/2011 |
| 8008337 | Azabicyclo[3.2.0] hept-3-yl compounds, a process for their preparation and pharmaceutical compositions containing them Compounds of formula (I): wherein: ALK represents an alkylene chain, W represents a group ... | 08/30/2011 |
| 7981921 | Crystalline forms of perindopril erbumine Disclosed are two new crystalline forms, δ and ε, of perindopril erbumine. Those forms are suitable as therapeutic active substances for medicaments for the treatment of cardiovascular diseases, especially high blood pressure and heart failure. The ε crystalline ... | 07/19/2011 |
| 7981920 | Addition salts of angiotensin-converting enzyme inhibitors with no donor acids, a process for their preparation and pharmaceutical compositions containing them Compounds of formula (I): (A)m·(B)n (I) wherein A represents an angiotensin-converting enzyme inhibitor compound containing at least one salt-forming basic function, B represents a compound containing at least one salt... | 07/19/2011 |
| 7956081 | Process for controlling protein to salt ratio in animal muscle protein composition and protein composition A low salt protein solution not capable of forming a gel is obtained from animal muscle tissue by forming an aqueous acidic protein solution which is filtered to remove salt and acid. The low salt protein solution can be formed into a gel by adding a physiologically... | 06/07/2011 |
| 7943656 | Crystal forms of saxagliptin and processes for preparing same Physical crystal structures of a compound of the formula I: are provided including the free base monohydrate thereof (form H-1) and the hydrochloric acid salt thereof, including hydrochloric acid salt containing 0.75 equiva... | 05/17/2011 |
| 7943655 | Polymorphic and pseudopolymorphic forms of trandolaprilat, pharmaceutical compositions and methods for production and use The present invention provides novel polymorphic and pseudopolymorphic forms of Trandolaprilat, including crystalline Trandolaprilat Form A, crystalline Trandolaprilat Form B, crystalline Trandolaprilat Form C, crystalline Trandolaprilat Form D, crystalline Trandola... | 05/17/2011 |
| 7915300 | Cysteine protease inhibitors A compound of the formula II wherein one of R1 and R2 is halo and the other is H or halo; R3 is C1-C4 straight or br... | 03/29/2011 |
| 7906547 | Azabicylic compounds, a process for their preparation and pharmaceutical compositions containing them Compounds of formula (I): wherein: ALK represents an alkylene chain, W represents a group selected from | 03/15/2011 |
| 7884124 | Fluoro-substituted inhibitors of D-amino acid oxidase This invention provides novel inhibitors of the enzyme D-amino acid oxidase as well as pharmaceutical compositions including the compounds of the invention. The invention also provides methods for the treatment and prevention of neurological disorders, such as neuro... | 02/08/2011 |
| 7879901 | Sublingual Formulations of Ketorolac or Salts Thereof The present invention refers to pharmaceutical compositions based on ketorolac or one of its salts pharmaceutically acceptable, as well as the use of ketorolac or one of its salts acceptable from pharmaceutical viewpoint, for preparation of a pharmaceutical composit... | 02/01/2011 |
| 7858655 | Drug preparation comprising α-lipoic acid, ambroxol and/or inhibitors of the angiotensin-converting enzyme (ACE) and its use for the treatment of neurodegenerative diseases The present invention concerns the use of Provided is a drug composition and a method for using the composition for the prevention and the therapy of neurodegenerative diseases. The combination comprises at least two of the following substances: α-lipoic acid; ambr... | 12/28/2010 |
| 7846961 | α crystalline form of the arginine salt of perindopril, a process for its preparation and pharmaceutical compositions containing it α-crystalline form of the compound of formula (I): characterized by its powder X-ray diffraction diagram. Medicinal products containing the same which are useful as inhibitors of angiotensin I converting enzyme. | 12/07/2010 |
| 7838547 | Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament The invention relates to aryl-substituted polycyclic amines of formula I, especially bicyclic amines, and to the physiologically tolerated salts and physiologically functional derivatives thereof; where the symbols and radi... | 11/23/2010 |
| 7820711 | Uses of selective inhibitors of HDAC8 for treatment of T-cell proliferative disorders Described herein are methods for treating a subject suffering from a T-cell lymphoma by administering to the subject a pharmaceutical composition containing a therapeutically effective amount of a selective inhibitor of histone deacetylase 8. Also described herein a... | 10/26/2010 |
| 7807704 | Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2 The present invention is directed to novel compounds and pharmaceutical compositions that inhibit the binding of the SDF-1 chemokine to the chemokine receptor CXCR4 and/or the binding of the SDF-1 or I-TAC chemokines to the chemokine receptor CCXCKR2 (CXCR7). These ... | 10/05/2010 |
| 7776904 | Azabicyclo [3.1.0] hexylphenyl derivatives as modulators of dopamine D3 receptors The present invention relates to novel compounds of formula (IA) or a salt thereof: wherein: A is attached to the phenyl group at the meta position or the para position relative to the cyclopropyl group, and is... | 08/17/2010 |
| 7772270 | Imino acid derivatives as inhibitors of matrix metalloproteinases The invention relates to a bicycloazaheterocyclyl carboxylic acid sulfonamide derivative of formula I herein, pharmaceutical preparation comprising it, process for preparing it and method for its pharmaceutical use. ... | 08/10/2010 |
| 7732477 | 2-heteroarylcarboxylic acid amides The invention relates to novel 2-heteroarylcarboxamides, processes for their preparation, and their use for producing medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning and/or memory. ... | 06/08/2010 |
| 7714018 | Heterocyclic antiviral compounds Chemokine receptor antagonists, in particular, 3,7-diazabicyclo[3.3.0]octane compounds according to formula (I) are antagonists of chemokine CCR5 receptors which are useful for treating or preventing an human immunodeficiency virus (HIV) infection, or treating AIDS ... | 05/11/2010 |
| 7714017 | Carboxylic acid peri-substituted bicyclics for occlusive artery disease Peri-substituted, fused bicyclic ring carboxylic acids useful for the treatment or prophylaxis of a prostaglandin-mediated disease or condition are disclosed. The compounds are of the general formula A representative exampl... | 05/11/2010 |
| 7705033 | Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof Methods and compounds for production of cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV are provided. ... | 04/27/2010 |
| 7691893 | Chemical compounds The present invention relates to (1S,6R)-6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane, pharmaceutically acceptable salts, prodrugs or solvates thereof; processes for their preparation, intermediates used in these processes, pharmaceutical ... | 04/06/2010 |
| 7678823 | Compounds for alzheimer's disease The invention provides novel compounds useful for the treatment of neurodegenerative disorders including Alzheimer's disease and dementia. The compounds have a substituents chosen from -L-C(═O)OH, -L-CH═CHC(═O)OH, -L-C(═O)NH2, -L-C(═O)NH(C1... | 03/16/2010 |
| 7674814 | Process for the preparation of perindopril and salts thereof The present invention relates to a process for the preparation of the ACE inhibitor (2S,3aS,7aS)-1-((2S)-2-(((1S)-1-(ethoxycarbonyl)butyl)amino)-1-oxopropyl)octahydro-1H-indol-2-carboxylic acid and of pharmaceutically acceptable salts thereof as well as to intermedi... | 03/09/2010 |
| 7666896 | Process for the preparation of perindopril A process for preparing perindopril (III) or a pharmaceutically acceptable salt thereof, which process comprises a substituted benzyl ester of (2S,3aS,7aS)-octahydroindole-2-carboxylic acid (I) with N—[(S)-carbethoxybutyl]-(S)-alanine (II) where R represents a hal... | 02/23/2010 |
| 7666897 | Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents Novel compounds useful as chemotherapeutic and chemopreventive agents are provided. The compounds are analogs of indole-3-carbinol metabolites wherein the structures and substituents of the compounds are selected to enhance the compounds' overall efficacy, particula... | 02/23/2010 |
| 7655689 | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function Fused cyclic compounds, methods of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds. ... | 02/02/2010 |
| 7615571 | Process for manufacture of pure (2S, 3aS, 7aS)-1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl) butyl]amino]-1-oxopropyl] octahydro-1H-indole-2-carboxylic acid and its tert. butyl amine salt New compounds useful as synthetic intermediates to synthesize perindopril, a new process for synthesizing perindopril, and new salts of perindopril. ... | 11/10/2009 |
| 7579370 | Fused heterocycles This invention provides fused heterocycles having the formula: in which R1 is a member selected from the group consisting of H, substituted or unsubstituted arylalkyl and substituted or unsubstituted heteroarylal... | 08/25/2009 |
| 7576120 | Azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them A compound selected from those of formula (I): wherein m and n, which may be identical or different, each represent an integer from 0 to 2 inclusive, with the sum of the two integers being... | 08/18/2009 |
